/주식/GERN
GERN

GERN

USD

Geron Corporation Common Stock

$1.150-0.050 (-4.167%)

실시간 가격

Healthcare
생명공학
미국

가격 차트

Loading Chart...

핵심 지표

시장 지표
기업 기본 정보
거래 통계

시장 지표

시가

$1.200

고가

$1.220

저가

$1.140

거래량

8.19M

기업 기본 정보

시가총액

733.7M

산업

생명공학

국가

United States

거래 통계

평균 거래량

7.83M

거래소

NMS

통화

USD

52주 범위

저가 $1.09현재가 $1.150고가 $4.5

관련 뉴스

BusinessWire

Geron Corporation to Present at Upcoming Investor Conferences

Geron Corporation (NASDAQ:GERN), a commercial-stage biopharmaceutical company aiming to change lives by changing the course of blood cancer, today announced that Harout Semerjian, Chief Executive Officer, is scheduled

더 보기
Geron Corporation to Present at Upcoming Investor Conferences
BusinessWire

Geron Corporation Announces Five Presentations Selected for ASH 2025 Highlighting Clinical Activity of RYTELO® (imetelstat) in Myeloid Hematologic Malignancies

New analysis from the Phase 3 IMerge clinical trial, accepted as an oral presentation, explores relationship between treatment-emergent cytopenias and clinical response in LR-MDS Additional poster presentations

더 보기
Geron Corporation Announces Five Presentations Selected for ASH 2025 Highlighting Clinical Activity of RYTELO® (imetelstat) in Myeloid Hematologic Malignancies